Company profile for Race Oncology

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Race Oncology is an Australian clinical-stage biopharma company focused on safer, more effective cancer treatments. Its lead drug, RC220, is a reformulated bisantrene?a small molecule chemotherapeutic with reduced cardiotoxicity compared to anthracyclines. Evaluated in 50+ trials with 1,500+ patients, bisantrene has shown promise both alone and in combination therapies. Race is also exploring its role in inhibiting the FTO pro...
Race Oncology is an Australian clinical-stage biopharma company focused on safer, more effective cancer treatments. Its lead drug, RC220, is a reformulated bisantrene?a small molecule chemotherapeutic with reduced cardiotoxicity compared to anthracyclines. Evaluated in 50+ trials with 1,500+ patients, bisantrene has shown promise both alone and in combination therapies. Race is also exploring its role in inhibiting the FTO protein linked to cancer via the m6A RNA pathway. The company is led by a seasoned team and guided by new clinical insights.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Australia
Address
Address
L36, 1 Macquarie Place, Sydney, NSW 2000
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Global ChemShow

Not Confirmed

envelop Contact Supplier

Global ChemShow

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty